BioCentury
ARTICLE | Distillery Therapeutics

Autoimmune disease

January 8, 2019 10:18 PM UTC

In vitro and mouse studies identified an NR1D1 agonist that could help treat MS. Optimization and in vitro binding assays of analogs of a previously reported benzohydrazide-based NR1D1 agonist yielded...